GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyper Corporation Inc (XKRX:065650) » Definitions » Cash Receipts from Fees and Commissions

Hyper (XKRX:065650) Cash Receipts from Fees and Commissions


View and export this data going back to 2003. Start your Free Trial

What is Hyper Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.


Hyper (XKRX:065650) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Woolim A-1401, 583, Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07547
Medifron DBT Co Ltd is a Korean clinical stage biopharmaceutical company. The company is focused on the development of Alzheimer's disease (AD) and neuropathic pain (NP) treatment and AD diagnostics.